Jean-Pierre Sommadossi - 05 Jun 2024 Form 4 Insider Report for Atea Pharmaceuticals, Inc. (AVIR)

Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Jean-Pierre Sommadossi
Issuer symbol
AVIR
Transactions as of
05 Jun 2024
Net transactions value
-$4,024
Form type
4
Filing time
07 Jun 2024, 18:34:21 UTC
Previous filing
02 Feb 2024
Next filing
19 Sep 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVIR Common Stock Sale $4,024 -1,006 -0.02% $4.00 5,923,994 05 Jun 2024 Held by JPM Partners LLC
holding AVIR Common Stock 116,557 05 Jun 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).